Advertisement

Activation and distribution of regulatory T cells in naïve and antigen-stimulated immune systems

  • Esther N.M. Nolte-’t Hoen
  • Marca H.M. Wauben
Chapter
Part of the Progress in Inflammation Research book series (PIR)

Keywords

Lymphoid Organ Mesenteric Lymph Node Mean Fluorescence Intensity High Endothelial Venule Cognate Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164PubMedGoogle Scholar
  2. 2.
    Asano M, Toda M, Sakaguchi N, Sakaguchi S (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184: 387–396PubMedGoogle Scholar
  3. 3.
    Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287–296PubMedGoogle Scholar
  4. 4.
    Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10: 1969–1980PubMedGoogle Scholar
  5. 5.
    Read S, Mauze S, Asseman C, Bean A, Coffman R, Powrie F (1998) CD38+ CD45RB(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur J Immunol 28: 3435–3447PubMedGoogle Scholar
  6. 6.
    Mason D (2001) T-cell-mediated control of autoimmunity. Arthritis Res 3: 133–135PubMedGoogle Scholar
  7. 7.
    Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389–400PubMedGoogle Scholar
  8. 8.
    Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455–458PubMedGoogle Scholar
  9. 9.
    Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182: 18–32PubMedGoogle Scholar
  10. 10.
    Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman, MA, Naji A, Caton AJ (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2: 301–306PubMedGoogle Scholar
  11. 11.
    Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21: 267–277PubMedGoogle Scholar
  12. 12.
    Pacholczyk R, Kraj P, Ignatowicz L (2002) Peptide specificity of thymic selection of CD4+CD25+ T cells. J Immunol 168: 613–620PubMedGoogle Scholar
  13. 13.
    Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW et al (2002) Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 32: 1621–1630Google Scholar
  14. 14.
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502–507PubMedGoogle Scholar
  15. 15.
    Taylor PA, Noelle RJ, Blazar BR (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193: 1311–1318PubMedGoogle Scholar
  16. 16.
    Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789–3796PubMedGoogle Scholar
  17. 17.
    Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253–257PubMedGoogle Scholar
  18. 18.
    von Herrath MG, Harrison LC (2003) Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 3: 223–232PubMedGoogle Scholar
  19. 19.
    Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 195: 603–616PubMedGoogle Scholar
  20. 20.
    Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895–903PubMedGoogle Scholar
  21. 21.
    Levings MK, Sangregorio R, Roncarolo MG (2001) Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193: 1295–1302PubMedGoogle Scholar
  22. 22.
    Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605–617PubMedGoogle Scholar
  23. 23.
    Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198: 737–746PubMedGoogle Scholar
  24. 24.
    Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK et al (2004) Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J Exp Med 199: 303–313PubMedGoogle Scholar
  25. 25.
    Nolte-’t Hoen EN, Wagenaar-Hilbers JP, Boot EP, Lin CH, Arkesteijn GJ, van Eden W, Taams LS, Wauben MHM (2004) Identification of a CD4(+)CD25(+) T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation. Eur J Immunol 34: 3016–3027PubMedGoogle Scholar
  26. 26.
    Thornton AM, Shevach EM (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164: 183–190PubMedGoogle Scholar
  27. 27.
    Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S (2000) Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 12: 1145–1155PubMedGoogle Scholar
  28. 28.
    Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, Brunner M, Scheffold A, Hamann A (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25 regulatory T cells. Proc Natl Acad Sci USA 99: 13031–13036PubMedGoogle Scholar
  29. 29.
    Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A (2002) Homeostasis and energy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 3: 33–41PubMedGoogle Scholar
  30. 30.
    Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235–247PubMedGoogle Scholar
  31. 31.
    Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN (2003) Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol 171: 4592–4603PubMedGoogle Scholar
  32. 32.
    Alyanakian MA, You S, Damotte D, Gouarin C, Esling A, Garcia C, Havouis S, Chatenoud L, Bach JF (2003) Diversity of regulatory CD4+T cells controlling distinct organspecific autoimmune diseases. Proc Natl Acad Sci USA 100: 15806–15811PubMedGoogle Scholar
  33. 33.
    McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne M C (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311–323PubMedGoogle Scholar
  34. 34.
    Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167: 1245–1253PubMedGoogle Scholar
  35. 35.
    Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI (2001) Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98: 2736–2744PubMedGoogle Scholar
  36. 36.
    Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E (2002) Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106: 190–199PubMedGoogle Scholar
  37. 37.
    Baecher-Allan C, Viglietta V, Hafler DA (2002) Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 169: 6210–6217Google Scholar
  38. 38.
    Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 91: 95PubMedGoogle Scholar
  39. 39.
    Kraal G, Mebius RE (1997) High endothelial venules: lymphocyte traffic control and controlled traffic. Adv Immunol 65: 347–395PubMedGoogle Scholar
  40. 40.
    Sallusto F, Lanzavecchia A (2000) Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177: 134–140PubMedGoogle Scholar
  41. 41.
    Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK (2003) Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 198: 249–258PubMedGoogle Scholar
  42. 42.
    Klein L, Khazaie K, von Boehmer H (2003) In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 100: 8886–8891PubMedGoogle Scholar
  43. 43.
    Battaglia A, Ferrandina G, Buzzonetti A, Malinconico P, Legge F, Salutari V, Scambia G, Fattorossi A (2003) Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire. Immunology 110: 304–312PubMedGoogle Scholar
  44. 44.
    Weiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18: 335–343PubMedGoogle Scholar
  45. 45.
    Kraal G, Wolvers DA (2001) Regulation of immunological mucosal tolerance. Arch Immunol Ther Exp (Warsz) 49(Suppl 1): S1–S6Google Scholar
  46. 46.
    Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM, Kraal G (1999) Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 162: 1994–1998PubMedGoogle Scholar
  47. 47.
    Weiner HL (2001) The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2: 671–672PubMedGoogle Scholar
  48. 48.
    Iwasaki A, Kelsall BL (2001) Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer’s patch dendritic cells. J Immunol 166: 4884–4890PubMedGoogle Scholar
  49. 49.
    Akbari O, DeKruyff RH, Umetsu DT (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2: 725–731PubMedGoogle Scholar
  50. 50.
    van Eden W, van der Zee R, Paul AG, Prakken BJ, Wendling U, Anderton SM, Wauben MH (1998) Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 19: 303–307PubMedGoogle Scholar
  51. 51.
    Unger WW, Jansen W, Wolvers DA, van Halteren AG, Kraal G, Samsom JN (2003) Nasal tolerance induces antigen-specific CD4+CD25 regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells. Int Immunol 15: 731–739PubMedGoogle Scholar
  52. 52.
    Nolte MA, Hamann A, Kraal G, Mebius RE (2002) The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106: 299–307PubMedGoogle Scholar
  53. 53.
    Nolte MA, Hoen EN, van Stijn A, Kraal G, Mebius RE (2000) Isolation of the intact white pulp. Quantitative and qualitative analysis of the cellular composition of the splenic compartments. Eur J Immunol 30: 626–634PubMedGoogle Scholar
  54. 54.
    Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211–5218PubMedGoogle Scholar
  55. 55.
    George TC, Bilsborough J, Viney JL, Norment AM (2003) High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur J Immunol 33: 502–511PubMedGoogle Scholar
  56. 56.
    Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 4123–4132PubMedGoogle Scholar
  57. 57.
    Lepault F, Gagnerault MC (2000) Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 164: 240–247PubMedGoogle Scholar
  58. 58.
    Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA (2003) CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 100: 10878–10883PubMedGoogle Scholar
  59. 59.
    Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33: 215–223PubMedGoogle Scholar
  60. 60.
    De Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, De Jager W, Pugayung G, Giannoni F, Rijkers G et al (2004) CD4(+)CD25(bright) Regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172: 6435–6443PubMedGoogle Scholar
  61. 61.
    D’Ambrosio D, Sinigaglia F, Adorini L (2003) Special attractions for suppressor T cells. Trends Immunol 24: 122–126PubMedGoogle Scholar
  62. 62.
    Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D’Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194: 847–853PubMedGoogle Scholar
  63. 63.
    Iellem A, Colantonio L, D’Ambrosio D (2003) Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur J Immunol 33: 1488–1496PubMedGoogle Scholar
  64. 64.
    Colantonio L, Iellem A, Sinigaglia F, D’Ambrosio D (2002) Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 32: 3506–3514PubMedGoogle Scholar
  65. 65.
    Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2: 1126–1132PubMedGoogle Scholar
  66. 66.
    Szanya V, Ermann J, Taylor C, Holness C, Fathman CG (2002) The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169: 2461–2465PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Esther N.M. Nolte-’t Hoen
    • 1
  • Marca H.M. Wauben
    • 2
  1. 1.Faculty of Biological SciencesImperial College LondonLondonUK
  2. 2.Department of Immunohematology and Blood TransfusionE3-Q, Leiden University Medical CenterLeidenThe Netherlands

Personalised recommendations